Navigation Links
Global Small Molecule Kinase Inhibitors Market to Reach $16.2 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.
Date:6/30/2009

GIA announces the release of a comprehensive global report on Small Molecule Kinase Inhibitors market. World market for small molecule kinase inhibitor drugs is projected to reach $16.2 billion by the year 2015. This is primarily driven by the rising interest over the potential of kinase inhibitors in effectively blocking, and modifying protein kinase triggered tumor cell metabolism, proliferation, and DNA damage. Strong growth in the future will be led by expansion of treatment indications in both oncology, and non-oncology disease areas.

San Jose, CA (PRWEB) June 30, 2009 -- With over 500 identified types of kinase proteins in the human body, its little surprise that these enzymes continue to remain important drug targets for major pharmaceutical drug developers, especially in the oncology space. Given their role in effectively disrupting cell signal pathways, kinase inhibitors are of special interest in the treatment of cancer. The unprecedented success witnessed in patient outcomes with the use of currently commercialized kinase inhibitors, such as, imatinib, among others, has ignited excitement over the untapped potential of this very potent class of drugs. Rising incidences of cancer, and the yet unmet treatment needs offer a strong business case for kinase inhibitors.    

The upcoming years are forecast to witness both the strong growth for multi-targeted kinase inhibitors, and the rising popularity of combination drug therapies. Growing incidences of tumor cell resistance to single targeted kinase inhibitor drugs is fingered as the key reason triggering interest in both combination drug therapies, and multi-targeted kinase inhibitors. For instance, growing incidences of resistance to Gleevec, has turned the spotlight on Nexavar, and Sutent, given the potential of these new drugs to offer the much awaited solution to the treatment impasse hitherto encountered. The
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3

Related biology technology :

1. Global Prescription Drugs Market to Cross $897 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
2. Cell Therapeutics Added to Russell 3000(R), Russell 2000(R) and Russell Global(R) Indexes
3. BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales
4. Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market
5. deCODE Reinstated to Nasdaq Global Market
6. BIO Ventures for Global Health Announces Management Changes
7. World Nanomedicine Market to Cross $160 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
8. Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita-based Center of Excellence with Global Convenience(TM)
9. Sugarcane as a Key Element Against Global Warming to be Highlighted at Green Week in Brussels
10. BD and FIND Achieve Milestone in Global Battle Against MDR-TB
11. Springborn Deploys eStudy(TM) Hosted Solution for Management of Global Environmental Testing

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Global Small Molecule Kinase Inhibitors Market to Reach $16.2 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.
Global Small Molecule Kinase Inhibitors Market to Reach $16.2 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.
(Date:11/24/2009)... . , Whether it,s CD packaging, containers o... Identification) are increasingly finding their wa...el objects or goods and identify them automaticall...read and process the data contained in the label. ...ion conditions of up to 100 degrees Celsius. But a...
(Date:11/24/2009)...investment bank KTA Capital,s client Neuren Pharma...onvertible note private placement with a U.S. inst...nged by KTA Capital as Neuren,s exclusive placemen...w York (PRWEB) November 23, 2009 -- The independen...;KTA Capital") has announced that its client ...
(Date:11/24/2009)... Iceland, November 24 de...d that it has received notice from,the Nasdaq Stoc...k will be,suspended as of November 30, 2009 and a ...Exchange Commission, which will remove deCODE,s co...any files an appeal to the Nasdaq,Listing Qualific...
(Date:11/24/2009)... Iceland, November 24 de...d the approval of all of its,"first day" motions b...laware,(the "Bankruptcy Court"). deCODE last week ...r 11 of the United States Bankruptcy Code with the... the Bankruptcy Court allow the company to continu...
Breaking Biology Technology:Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...uXi PharmaTech (NYSE:,WX), China,s premier provide...nced today that it has been ranked the 28th in the...ing of the 50 fastest growing technology,companies...Marriott Hotel,Shanghai at Tomorrow Square, Shangh...cgi-bin/prnh/20040705/CNM002LOGO ) The Deloitte ...
...New York on November 5th, SAN DIEGO, Oct. 26 Fav...mpany developing patient-specific, active,immunoth...ed that the,Company will present at three upcoming....com/cgi-bin/prnh/20031013/LAM095LOGO ), -- Richa...nt at the BIOCOM Investor Conference at 11:00 ...
...AL), a life science company dedicated to providing...cts to the world,s researchers, and Oxford,BioMedi...ounced today that,they received a key order confir...perty owned by Oxford BioMedica and licensed exclu... ruling was part of the,construction of patent cla...
Other Biology Technology:WuXi PharmaTech (NYSE: WX) Ranked the 28th of Deloitte Technology Fast 50 China 2Favrille to Present at BIOCOM Investor Conference, Acumen BioFin Rodman & Renshaw Healthcare Conference and CIBC World Markets Healthcare Conference 2Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute 2Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute 3
(Date:11/26/2009)...taphylococcus Aureus ) and other drug-resistant ba...plasma prototype devices have been developed to of...ocktails. , Two prototype devices have been deve...kin (e.g. hands and feet) in hospitals and public ...d another to shoot bacteria-killing agents into in...
(Date:11/25/2009)...ve easy lives. In addition to mammalian immune sys...ies called bacteriophages, viruses that kill half ...bacteria and another class of microorganisms calle...s such as deep-sea volcanic vents) manage just fin... defense system that helps protect them from many ...
(Date:11/25/2009)... Soil is the linchpin of the environment, where a...e that, many students see soil as "just dirt" a p...e educators are challenged with the task of helpin...mportance of soil in the environment. , A colla... teachers at University of Nebraska-Lincoln, Orego...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3It's not just dirt! 2Surprise 21 Jamba Juice Treats Lucky San Francisco Cable Car Passengers to Free Rides on Saturday October 17 59621 1Surprise 21 Jamba Juice Treats Lucky San Francisco Cable Car Passengers to Free Rides on Saturday October 17 59621 2Surprise 21 Jamba Juice Treats Lucky San Francisco Cable Car Passengers to Free Rides on Saturday October 17 59621 3Houston Plastic Surgeon Seeing Growth in Aesthetic Enhancement Procedures Despite Rough Economy 59620 1Houston Plastic Surgeon Seeing Growth in Aesthetic Enhancement Procedures Despite Rough Economy 59620 2Houston Plastic Surgeon Seeing Growth in Aesthetic Enhancement Procedures Despite Rough Economy 59620 3Swanson Health Products Joins Peggy Fleming in Promoting the Heart Health Benefits of Ubiquinol a CoQ10 Dietary Supplement 59616 1Swanson Health Products Joins Peggy Fleming in Promoting the Heart Health Benefits of Ubiquinol a CoQ10 Dietary Supplement 59616 2Swanson Health Products Joins Peggy Fleming in Promoting the Heart Health Benefits of Ubiquinol a CoQ10 Dietary Supplement 59616 3
...ot a source of carbon dioxide to the atmosphere, a...er 25) in the journal Science. The study was carri...m UC Davis, the Catholic University of Leuven in B... Carbon emissions are of great concern worldwide ...t in the Earth,s atmosphere and are a major cause ...
... a transporter of cholesterol, may also contribute... mechanism, according to a report published online...nk between native LDL (nLDL) and the vascular endo...lays a central role in blood vessel formation. , ...om the liver to peripheral tissues. During transit...
...e University was awarded a three-year grant from t...cultural and economic impacts of the "biofuels rev...The $696,827 grant comes from the department,s Eth...on Alternative Bioenergy Technologies, Synthetic G...s from K-State,s department of sociology, anthropo...
Other Biology News:Agricultural soil erosion is not adding to global warming 2K-State sociologists use Department of Energy grant 2
Wash Solution from CHEMICON
Agarose, high EEO, Molecular Biology Grade from Research Organics, Inc.
Donor Bovine Serum - 500mL from Biomeda Corporation
Rabbit Anti-Human Q86TS7 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Biology Products: